Lili Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
Papers in
-
- Cancer-related molecular mechanisms research 39
- MicroRNA in disease regulation 29
-
- Prostate Cancer Treatment and Research 7
- Neonatal Respiratory Health Research 6
- Co-authors
- Yang Zhao (11 shared papers)Shuo Chen (9 shared papers)Donghua Liu (2 shared papers)Zhihong Liu (2 shared papers)Na Zhang (2 shared papers)Zhi‐Hong Zong (8 shared papers)Tisato Kajiyama (1 shared paper)Naoya Ogata (1 shared paper)
- Journals
- Journal of Cellular and Molecular Medicine (4 papers)Annals of Translational Medicine (3 papers)The Journal of Physical Chemistry A (3 papers)Medical Oncology (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lili Wang
168 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 156
- Cancer Research 1.9k
- Molecular Biology 2.4k
- Pharmaceutical Science 138
- Biomaterials 234
- Pulmonary and Respiratory Medicine 494
Countries citing papers authored by Lili Wang
This map shows the geographic impact of Lili Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Wang more than expected).
Fields of papers citing papers by Lili Wang
This network shows the impact of papers produced by Lili Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Wang. The network helps show where Lili Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lili Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 342 | |
| 2 | 2001 | 303 | |
| 3 | 2011 | 218 | |
| 4 | 2021 | 148 | |
| 5 | 2001 | 136 | |
| 6 | 2018 | 116 | |
| 7 | 2012 | 109 | |
| 8 | 2014 | 106 | |
| 9 | 2019 | 104 | |
| 10 | 2011 | 100 | |
| 11 | 2017 | 100 | |
| 12 | 2013 | 97 | |
| 13 | 2014 | 91 | |
| 14 | 2017 | 91 | |
| 15 | 2017 | 86 | |
| 16 | 2014 | 84 | |
| 17 | 2022 | 73 | |
| 18 | 2013 | 69 | |
| 19 | 2017 | 65 | |
| 20 | 2015 | 61 |
About Lili Wang
Lili Wang is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Pathology and Forensic Medicine, having authored 178 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (39 papers), MicroRNA in disease regulation (29 papers), Circular RNAs in diseases (23 papers), RNA modifications and cancer (11 papers), Prostate Cancer Treatment and Research (7 papers), RNA Research and Splicing (7 papers), Neonatal Respiratory Health Research (6 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (2.4k citations), Pharmaceutical Science (138 citations), Biomaterials (234 citations) and Pulmonary and Respiratory Medicine (494 citations). Lili Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yang Zhao, Shuo Chen, Donghua Liu, Zhihong Liu, Na Zhang, Zhi‐Hong Zong, Tisato Kajiyama, Naoya Ogata, Sono Sasaki and Lutao Du. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Annals of Translational Medicine, The Journal of Physical Chemistry A, Medical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.